New Key Statistics Module, Z-Score and F-Score
OTCPK:DNPUF Key Ratios
| Market Cap $ M | 1,007.39 |
| Enterprise Value $ M | 3,374.67 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.46 |
| Price/Sales | 0.48 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2,340.00 |
| EPS (TTM) $ | -3.11 |
| Beneish M-Score | -2.3 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -203.80 |
| EV-to-EBIT | -3.90 |
| EV-to-EBITDA | -5.39 |
| PEG | -- |
| Shares Outstanding M | 397.29 |
| Net Margin (%) | -52.59 |
| Operating Margin % | -53.57 |
| Pre-tax Margin (%) | -47.02 |
| Quick Ratio | 0.38 |
| Current Ratio | 0.63 |
| ROA % (ttm) | -14.83 |
| ROE % (ttm) | -39.22 |
| ROIC % (ttm) | -18.71 |
| Dividend Yield % | 1.80 |
| Altman Z-Score | 0.07 |
DNPUF Number of Guru Trades
DNPUF Volume of Guru Trades
Gurus Latest Trades with OTCPK:DNPUF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:DNPUF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sumitomo Pharma Co Ltd Insider Transactions
No Available Data
News about OTCPK:DNPUF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers